← European Medicine Shortage Tracker · all medicines
Availability information only — Mobi Doctor doesn't sell medicines; check with a pharmacy.
Cinnarizina currently has availability issues reported in 2 European registers: Greece, Italy.
Shortage ATC N07CA02 · also listed as: Cinnarizine · CINNARIZINA · data refreshed 11 September 2026
As of 11 September 2026, 2 of the 9 tracked registers list current availability issues for Cinnarizina, covering 2 affected product presentations. The longest-running open report was filed in Greece on 2026-07-03 and has now been open for about 2 months. Where agencies state a cause, commercial decisions or discontinuation lead with 1 of the 1 stated-cause reports. Notably, 1 report has already passed the expected-resolution date without closing — prognoses for this medicine should be read as estimates, not commitments. Momentum is current, not historical: 2 of the open reports were filed within the last 90 days. Registers in Greece, Italy indicate that alternatives or equivalents are available — a pharmacist or doctor can advise on switching. In the WHO ATC classification, Cinnarizina is coded N07CA02 — a medicine acting on the nervous system — so clinically related products appear under “Related medicines” below.
| Where | Status & products | Since | Expected end | Reason / alternatives | Source |
|---|---|---|---|---|---|
| 🇬🇷 Greece | Limited availability Cinnarizine | 2026-07-03 | 2026-07-15 | Ν+Φ Ι.Φ.Ε.Τ. ΑΝΑΜΕΝΕΤΑΙ Alternatives: ΑΝΑΜΕΝΕΤΑΙ | register ↗ |
| 🇮🇹 Italy | Shortage TOLIMAN | 2027-01-01 | — | Cessata commercializzazione definitiva Alternatives: AIFA: equivalents with the same active substance are available. | register ↗ |
Every individual register entry for Cinnarizina in the tracked sources, newest first — including resolved and discontinued reports.
| Reg. | Product | Status | Reported | Expected end | Stated reason |
|---|---|---|---|---|---|
| 🇮🇹 IT | TOLIMAN | Shortage | 2027-01-01 | — | Cessata commercializzazione definitiva |
| 🇬🇷 GR | Cinnarizine | Limited availability | 2026-07-03 | 2026-07-15 | Ν+Φ Ι.Φ.Ε.Τ. ΑΝΑΜΕΝΕΤΑΙ |
Yes. As of 11 September 2026, availability issues are reported in: Greece, Italy. Availability is national — a shortage in one country does not mean it is short everywhere.
2 of the active register entries indicate alternatives or equivalents (same active substance or an alternative treatment). Do not switch on your own — a pharmacist or prescriber can confirm the right substitute in your country.
Directly from the official medicines-agency registers that list Cinnarizina: EOF limited-availability list (Greece), AIFA (Italy). Every row on this page links to the underlying official record, and the dataset is refreshed from the primary sources every morning. Cross-language matching groups the same active substance across registers, so national spellings all resolve to this page.
Pharmacies, patient sites and newsrooms are welcome to embed the live status of Cinnarizina — free, with attribution. Copy this snippet:
<iframe src="https://www.mobidoctor.eu/medicine-shortages/medicine-shortages/cinnarizina/embed.html" width="100%" height="150" loading="lazy" style="border:1px solid #e1e0d9;border-radius:12px" title="Cinnarizina availability in Europe"></iframe> <p style="font-size:12px">Source: <a href="https://www.mobidoctor.eu/medicine-shortages/medicine-shortages/cinnarizina/">Cinnarizina shortage status — European Medicine Shortage Tracker</a> by MobiDoctor</p>